Terms: = Head and neck cancer AND EGFR, mENA, 1956, ENSG00000146648, P00533, ERBB1, ERBB AND Clinical Outcome
122 results:
1. FUT8-mediated aberrant N-glycosylation of SEMA7A promotes head and neck squamous cell carcinoma progression.
Liu Z; Meng X; Zhang Y; Sun J; Tang X; Zhang Z; Liu L; He Y
Int J Oral Sci; 2024 Mar; 16(1):26. PubMed ID: 38548747
[TBL] [Abstract] [Full Text] [Related]
2. Resistance of HNSCC cell models to pan-FGFR inhibition depends on the EMT phenotype associating with clinical outcome.
Broghammer F; Korovina I; Gouda M; Celotti M; van Es J; Lange I; Brunner C; Mircetic J; Coppes RP; Gires O; Dahl A; Seifert M; Cordes N
Mol Cancer; 2024 Feb; 23(1):39. PubMed ID: 38378518
[TBL] [Abstract] [Full Text] [Related]
3. Study of the association of the known prognostic variables with egfr expression in head and neck squamous cell carcinomas.
Jadhav T; Malik A; Kashif AW; Shelly D; Mishra PS; Baranwal AK; Sahu R
Indian J Pathol Microbiol; 2024; 67(1):36-45. PubMed ID: 38358186
[TBL] [Abstract] [Full Text] [Related]
4. Evaluation of egfr in prognostic characterization in histopathological variants of oral squamous cell carcinoma.
Tyagi D; Singhal M; Gulati N; Jain A; Shetty DC
J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S743-S746. PubMed ID: 38384049
[TBL] [Abstract] [Full Text] [Related]
5. Oncogene-specific differences in tumor mutational burden, PD-L1 expression, and outcomes from immunotherapy in non-small cell lung cancer.
Negrao MV; Skoulidis F; Montesion M; Schulze K; Bara I; Shen V; Xu H; Hu S; Sui D; Elamin YY; Le X; Goldberg ME; Murugesan K; Wu CJ; Zhang J; Barreto DS; Robichaux JP; Reuben A; Cascone T; Gay CM; Mitchell KG; Hong L; Rinsurongkawong W; Roth JA; Swisher SG; Lee J; Tsao A; Papadimitrakopoulou V; Gibbons DL; Glisson BS; Singal G; Miller VA; Alexander B; Frampton G; Albacker LA; Shames D; Zhang J; Heymach JV
J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34376553
[TBL] [Abstract] [Full Text] [Related]
6. Dual blockade of egfr and CDK4/6 delays head and neck squamous cell carcinoma progression by inducing metabolic rewiring.
Chaudhary S; Pothuraju R; Rachagani S; Siddiqui JA; Atri P; Mallya K; Nasser MW; Sayed Z; Lyden ER; Smith L; Gupta SD; Ralhan R; Lakshmanan I; Jones DT; Ganti AK; Macha MA; Batra SK
Cancer Lett; 2021 Jul; 510():79-92. PubMed ID: 33878394
[TBL] [Abstract] [Full Text] [Related]
7. Combining radiation to egfr and Bcl-2 blockade: a new approach to target cancer stem cells in head and neck squamous cell carcinoma.
Guy JB; Espenel S; Louati S; Gauthier A; Garcia MA; Vial N; Malésys C; Ardail D; Alphonse G; Wozny AS; Rodriguez-Lafrasse C; Magné N
J Cancer Res Clin Oncol; 2021 Jul; 147(7):1905-1916. PubMed ID: 33791846
[TBL] [Abstract] [Full Text] [Related]
8. Comprehensive functional genomic analyses link APC somatic mutation and mRNA-miRNA networks to the clinical outcome of stage-III colorectal cancer patients.
Chiang SF; Huang HH; Tsai WS; Chin-Ming Tan B; Yang CY; Huang PJ; Yi-Feng Chang I; Lin J; Lu PS; Chin E; Liu YH; Yu JS; Chiang JM; Hung HY; You JF; Liu H
Biomed J; 2022 Apr; 45(2):347-360. PubMed ID: 35550340
[TBL] [Abstract] [Full Text] [Related]
9. A YAP/FOXM1 axis mediates EMT-associated egfr inhibitor resistance and increased expression of spindle assembly checkpoint components.
Nilsson MB; Sun H; Robichaux J; Pfeifer M; McDermott U; Travers J; Diao L; Xi Y; Tong P; Shen L; Hofstad M; Kawakami M; Le X; Liu X; Fan Y; Poteete A; Hu L; Negrao MV; Tran H; Dmitrovsky E; Peng D; Gibbons DL; Wang J; Heymach JV
Sci Transl Med; 2020 Sep; 12(559):. PubMed ID: 32878980
[TBL] [Abstract] [Full Text] [Related]
10. A novel immune checkpoint-related seven-gene signature for predicting prognosis and immunotherapy response in melanoma.
Tian M; Yang J; Han J; He J; Liao W
Int Immunopharmacol; 2020 Oct; 87():106821. PubMed ID: 32731180
[TBL] [Abstract] [Full Text] [Related]
11. Comparison of thyroid hormone withdrawal and recombinant human thyroid-stimulating hormone administration for adjuvant therapy in patients with intermediate- to high-risk differentiated thyroid cancer.
Iizuka Y; Katagiri T; Ogura K; Inoue M; Nakamura K; Mizowaki T
Ann Nucl Med; 2020 Oct; 34(10):736-741. PubMed ID: 32643022
[TBL] [Abstract] [Full Text] [Related]
12. Expression and function of epithelial cell adhesion molecule EpCAM: where are we after 40 years?
Gires O; Pan M; Schinke H; Canis M; Baeuerle PA
Cancer Metastasis Rev; 2020 Sep; 39(3):969-987. PubMed ID: 32507912
[TBL] [Abstract] [Full Text] [Related]
13. erbb3, a possible prognostic factor of head and neck squamous cell carcinoma.
Kim H; Choi JY; Rah YC; Ahn JC; Kim H; Jeong WJ; Ahn SH
Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Apr; 129(4):377-387. PubMed ID: 32081558
[TBL] [Abstract] [Full Text] [Related]
14. Molecular profiling of circulating tumor cells predicts clinical outcome in head and neck squamous cell carcinoma.
Tada H; Takahashi H; Kuwabara-Yokobori Y; Shino M; Chikamatsu K
Oral Oncol; 2020 Mar; 102():104558. PubMed ID: 32044652
[TBL] [Abstract] [Full Text] [Related]
15. Stathmin and egfr correlates to HPV status and clinical outcome in sinonasal inverted papilloma.
Elliot A; Nasman A; Westman M; Hammarstedt-Nordenvall L; Stjarne P; Marklund L
Rhinology; 2020 Feb; 58(1):74-79. PubMed ID: 31710049
[TBL] [Abstract] [Full Text] [Related]
16. Association between egfr expression and clinical outcome of laryngeal HPV squamous cell carcinoma.
Kontić M; Čolović Z; Paladin I; Gabelica M; Barić A; Pešutić-Pisac V
Acta Otolaryngol; 2019 Oct; 139(10):913-917. PubMed ID: 31430224
[No Abstract] [Full Text] [Related]
17. clinical Impact of Rare and Compound Mutations of Epidermal Growth Factor Receptor in Patients With Non-Small-Cell Lung cancer.
Martin J; Lehmann A; Klauschen F; Hummel M; Lenze D; Grohé C; Tessmer A; Gottschalk J; Schmidt B; Pau HW; Witt C; Moegling S; Kromminga R; Jöhrens K
Clin Lung Cancer; 2019 Sep; 20(5):350-362.e4. PubMed ID: 31175009
[TBL] [Abstract] [Full Text] [Related]
18. IFIT1 and IFIT3 promote oral squamous cell carcinoma metastasis and contribute to the anti-tumor effect of gefitinib via enhancing p-egfr recycling.
Pidugu VK; Wu MM; Yen AH; Pidugu HB; Chang KW; Liu CJ; Lee TC
Oncogene; 2019 Apr; 38(17):3232-3247. PubMed ID: 30626937
[TBL] [Abstract] [Full Text] [Related]
19. EpCAM ectodomain EpEX is a ligand of egfr that counteracts EGF-mediated epithelial-mesenchymal transition through modulation of phospho-ERK1/2 in head and neck cancers.
Pan M; Schinke H; Luxenburger E; Kranz G; Shakhtour J; Libl D; Huang Y; Gaber A; Pavšič M; Lenarčič B; Kitz J; Jakob M; Schwenk-Zieger S; Canis M; Hess J; Unger K; Baumeister P; Gires O
PLoS Biol; 2018 Sep; 16(9):e2006624. PubMed ID: 30261040
[TBL] [Abstract] [Full Text] [Related]
20. A prognostic mRNA expression signature of four 16q24.3 genes in radio(chemo)therapy-treated head and neck squamous cell carcinoma (HNSCC).
Wintergerst L; Selmansberger M; Maihoefer C; Schüttrumpf L; Walch A; Wilke C; Pitea A; Woischke C; Baumeister P; Kirchner T; Belka C; Ganswindt U; Zitzelsberger H; Unger K; Hess J
Mol Oncol; 2018 Dec; 12(12):2085-2101. PubMed ID: 30259648
[TBL] [Abstract] [Full Text] [Related]
[Next]
